Catalyst Pharmaceuticals (CPRX) EBT Margin (2018 - 2026)
Catalyst Pharmaceuticals' EBT Margin came in at 56.38% for Q1 2026, up 5.98 percentage points from 50.41% a year earlier and up 9.27 percentage points from the prior quarter.
Catalyst Pharmaceuticals (CPRX) EBT Margin (2018 - 2026) Analysis & Trends
Over the trailing twelve months to Mar 31, 2026, Catalyst Pharmaceuticals reported EBT Margin of 49.66%, up 1.32 percentage points year-over-year; for FY2025, it came in at 48.14%, up 4.16 percentage points from FY2024.
- EBT Margin carries a five-year change of +12.96 percentage points (FY2020 to FY2025).
- Going back by year, EBT Margin was 43.98% in FY2024 (+20.25 pp), 23.73% in FY2023 (-25.15 pp), 48.89% in FY2022 (+11.49 pp) and 37.40% in FY2021 (+2.22 pp).
- The Q1 2026 figure represents the highest quarterly EBT Margin in data going back to Q4 2018.
- Year-over-year, EBT Margin increased in six of the last eight quarters, with an average year-over-year change of +14.40 percentage points.
- The fastest year-over-year change in EBT Margin over five years came in Q3 2024 (a gain of 81.48 percentage points), and the weakest in Q3 2023 (a drop of 82.46 percentage points).
- Business Quant data shows CPRX's EBT Margin at 47.11% (Q4 2025), 47.87% (Q3 2025) and 47.28% (Q2 2025) in the three quarters before Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 41.75% |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 1.04 Bn | 134.92 Mn | 56.38% |
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 56.38% |
| Dec 31, 2025 | 47.11% |
| Sep 30, 2025 | 47.87% |
| Jun 30, 2025 | 47.28% |
| Mar 31, 2025 | 50.41% |
| Dec 31, 2024 | 52.31% |
| Sep 30, 2024 | 44.45% |
| Jun 30, 2024 | 45.46% |
| Mar 31, 2024 | 29.53% |
| Dec 31, 2023 | 42.24% |
| Sep 30, 2023 | -37.03% |
| Jun 30, 2023 | 48.72% |
| Mar 31, 2023 | 43.71% |
| Dec 31, 2022 | 54.33% |
| Sep 30, 2022 | 45.43% |
| Jun 30, 2022 | 53.18% |
| Mar 31, 2022 | 40.52% |
| Dec 31, 2021 | 33.45% |
| Sep 30, 2021 | 39.14% |
| Jun 30, 2021 | 43.72% |
Catalyst Pharmaceuticals EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=CPRX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "CPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=CPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();